This receptor was also not modulated by regular opiate agonists, which consist of morphine, fentanyl, buprenorphine, or antagonists like naloxone. In an exceptionally rat solution, it had been recognized that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3’s inhibitory action, triggering an Total Enhance in opiate receptor